Search Within

James A Fagin

Formats
  1. Journal Article (128)
  2. Meeting Abstract (42)
  3. Review (4)
  4. Editorial (3)
  5. Book Section (2)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (181)
  2. Department of Medicine (181)
  3. Division of Subspecialty Medicine (181)
  4. Endocrinology (181)
  5. GSK Faculty (181)
  6. Human Oncology and Pathogenesis Program (181)

More Groups

People
  1. Ronald Ghossein (85)
  2. Jeffrey Knauf (58)
  3. Robert Tuttle (57)
  4. Eric Sherman (35)
  5. Alan Ho (31)
  6. Ian Ganly (26)

More People

Years
  1. 2025 (4)
  2. 2024 (9)
  3. 2023 (10)
  4. 2022 (23)
  5. 2021 (7)
  6. 2020 (9)

More Years

Publications
  1. Thyroid (18)
  2. Cancer Research (17)
  3. Journal of Clinical Oncology (16)
  4. Journal of Clinical Endocrinology and Metabolism (15)
  5. Modern Pathology (8)
  6. Laboratory Investigation (7)

More Publications

Publishers
  1. American Association for Cancer Research (30)
  2. Mary Ann Liebert, Inc (19)
  3. Nature Publishing Group (18)
  4. American Society of Clinical Oncology (17)
  5. Oxford University Press (17)
  6. Springer (10)

More Publishers

Results (181)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Enhancing radioiodine (RAI) incorporation into BRAF(V600E)-mutant, RAI-refractory thyroid cancers with the BRAF inhibitor vemurafenib: A pilot study
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Baxi, S. S.; Grewal, R. K.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M.; Fish, S.; Boucai, L.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • The authors reply
    Journal Article

    Fagin, J. A.; Wells, S. A.
    New England Journal of Medicine (2016)

    Fulltext@MSK | Save
  • The authors reply
    Journal Article

    Fagin, J. A.; Wells, S. A., Jr.
    New England Journal of Medicine (2016)

    Fulltext@MSK | Save
  • An integrated model of RAF inhibitor action predicts inhibitor activity against oncogenic BRAF signaling
    Journal Article

    Karoulia, Z.; Wu, Y.; Ahmed, T. A.; Xin, Q.; Bollard, J.; Krepler, C.; Wu, X.; Zhang, C.; Bollag, G.; Herlyn, M.; more...
    Cancer Cell (2016)

    Fulltext@MSK | Save
  • Sustained ERK inhibition maximizes responses of Braf(V600E) thyroid cancers to radioiodine
    Journal Article

    Nagarajah, J.; Le, M.; Knauf, J. A.; Ferrandino, G.; Montero-Conde, C.; Pillarsetty, N.; Bolaender, A.; Irwin, C.; Krishnamoorthy, G. P.; Saqcena, M.; more...
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save
  • Mammary analog secretory carcinoma of the thyroid gland: A primary thyroid adenocarcinoma harboring ETV6-NTRK3 fusion
    Journal Article

    Dogan, S.; Wang, L.; Ptashkin, R. N.; Dawson, R. R.; Shah, J. P.; Sherman, E. J.; Tuttle, R. M.; Fagin, J. A.; Klimstra, D. S.; Katabi, N.; more...
    Modern Pathology (2016)

    Fulltext@MSK | Save
  • Biologic and clinical perspectives on thyroid cancer
    Journal Article

    Fagin, J. A.; Wells, S. A.
    New England Journal of Medicine (2016)

    Fulltext@MSK | Save
  • Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers
    Journal Article

    Landa, I.; Ibrahimpasic, T.; Boucai, L.; Sinha, R.; Knauf, J. A.; Shah, R. H.; Dogan, S.; Ricarte-Filho, J. C.; Krishnamoorthy, G. P.; Xu, B.; more...
    Journal of Clinical Investigation (2016)

    Fulltext@MSK | Save
  • Altiratinib is a potent inhibitor of TRK kinases and is efficacious in TRK-fusion driven cancer models
    Meeting Abstract

    Smith, B. D.; Leary, C. B.; Turner, B. A.; Kaufman, M. D.; Wise, S. C.; Garcia-Rendueles, M. E. R.; Fagin, J. A.; Flynn, D. L.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Monitoring of re-differentiation effect of radio-iodine refractory thyroid cancer using the new tracer F-18-TFB
    Meeting Abstract

    Nagarajah, J.; Bolander, A.; Irwin, C.; Fagin, J. A.; Weber, W. A.
    European Journal of Nuclear Medicine and Molecular Imaging (2015)

    Fulltext@MSK | Save